购物车
- 全部删除
- 您的购物车当前为空
Nedometinib (NFX-179) 是一种选择性丝裂原活化蛋白激酶激酶 (MEK1) 抑制剂,具有抗癌抗肿瘤活性,抑制皮肤中的 MAPK 通路信号传导,以剂量依赖性方式抑制人鳞状细胞系的生长,可用于研究恶性肿瘤。
为众多的药物研发团队赋能,
让新药发现更简单!
Nedometinib (NFX-179) 是一种选择性丝裂原活化蛋白激酶激酶 (MEK1) 抑制剂,具有抗癌抗肿瘤活性,抑制皮肤中的 MAPK 通路信号传导,以剂量依赖性方式抑制人鳞状细胞系的生长,可用于研究恶性肿瘤。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,280 | 现货 | |
5 mg | ¥ 2,820 | 现货 | |
10 mg | ¥ 4,480 | 现货 | |
25 mg | ¥ 6,930 | 现货 | |
50 mg | ¥ 9,330 | 现货 | |
100 mg | ¥ 12,600 | 现货 |
产品描述 | Nedometinib (NFX-179) is a selective mitogen-activated protein kinase kinase (MEK1) inhibitor with anticancer and antitumor activity, inhibits MAPK pathway signaling in the skin, inhibits the growth of human squamous cell lines in a dose-dependent manner, and can be used to study malignant tumors. |
别名 | NFX-179, NFX179, NFX 179 |
分子量 | 470.24 |
分子式 | C17H16FIN4O3 |
CAS No. | 2252314-46-6 |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 80 mg/mL (170.13 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.